Skip to main content

Table 4 Post hoc comparisons for significant glm models predicting overexpression

From: Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways

   BCRP ER
   Mean diff SE 95% LCL 95% UCL p Mean diff SE 95% LCL 95% UCL p
Carcinoma and serous Clear cell 0 0.08 -0.16 0.16 .993 0.33 0.08 0.17 0.49 .000*
Carcinoma and serous Endometriod 0.2 0.10 0.01 0.38 .039 -0.03 0.10 -0.22 0.17 .783
Carcinoma and serous Other 0.13 0.09 -0.05 0.31 .155 0.08 0.10 -0.11 0.27 .405
Clear cell Endometriod 0.2 0.12 -0.04 0.44 .110 -0.36 0.12 -0.60 -0.12 .003*
Clear cell Other 0.13 0.12 -0.11 0.37 .279 -0.25 0.12 -0.48 -0.02 .037
Endometriod Other -0.07 0.13 -0.32 0.19 .609 0.11 0.13 -0.15 0.37 .417
   MGMT RRM1
   Mean diff SE 95% LCL 95% UCL p Mean diff SE 95% LCL 95% UCL p
Carcinoma and serous Clear cell 0.31 0.11 0.10 0.52 0.00* 0.33 .081 .17 .49 .000*
Carcinoma and serous Endometriod 0.00 0.05 -0.10 0.10 0.95 0.22 .086 .05 .39 .010*
Carcinoma and serous Other 0.04 0.06 -0.08 0.16 0.52 -.10 .097 -.29 .09 .311
Clear cell Endometriod -0.31 0.12 -0.54 -0.08 0.00* -.11 .112 -.33 .11 .338
Clear cell Other -0.27 0.12 -0.51 -0.04 0.02 -0.43 .121 -.67 -.19 .000*
Endometriod Other 0.04 0.08 -0.11 0.18 0.95 -0.32 .124 -.56 -.08 .010*
   PTEN      
   Mean diff SE 95% LCL 95% UCL p      
Carcinoma and serous Clear cell .17 .112 -.05 .39 .128      
Carcinoma and serous Endometriod 0.22 .097 .03 .41 .024      
Carcinoma and serous Other .04 .096 -.15 .23 .679      
Clear cell Endometriod .05 .144 -.23 .33 .740      
Clear cell Other -.13 .143 -.41 .15 .359      
Endometriod Other -.18 .131 -.44 .08 .174      
  1. *P < 0.05.